Cardiovascular Research & Innovation
The HEARTBEAT Study
The HEARTBEAT study, conducted by the Tulane University Heart & Vascular Institute and Tulane Research Innovation for Arrhythmia Disorders (TRIAD) in collaboration with Samsung Research America, tests the relationship between biological signals collected by a Samsung Galaxy Smartwatch and heart-related health problems. This research may help enhance the prediction, identification, and understanding of cardiovascular diseases and comorbidities. Enrollment is pending.
Click below to complete our screening questionnaire and determine your eligibility for participation in the clinical trial.



The HEARTBEAT Study: Engaging & Easy
Participants can easily learn more about their own health while contributing to heart health research, all in under a minute a day. They are paving the way for a more proactive and personalized approach to patient care.

Gain Knowledge
Participants learn more about their heart and lifestyle habits that may help improve their overall wellbeing.

Advance Research
By using real-time data from wearable devices our project aims to bridge the knowledge gaps in current clinical practice.
Eligibility Requirements
Here are the main requirements for participation (other inclusion criteria may apply):
- At least 18 years of age.
- Have a heart-related health condition(s):
- Heart failure, cardiac arrhythmia(s), chronic kidney disease, coronary artery disease, history of stroke/transient ischemic attack, or diabetes mellitus.
- If you don’t have one of the previous health conditions you can still participate in our healthy control group! (while spots are available)

Privacy & Security: Vital Importance
The HEARTBEAT App is designed with privacy and security as a priority. All the electronic health information including demographics, vitals, labs, biometric information from the Samsung Galaxy Smartwatch and health records are de-identified and stored securely with HIPAA compliant processes.